Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank78
5Y CAGR-8.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-8.0%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$31000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$47000.00+20.5%
2019$39000.00+69.6%
2018$23000.00-
2017$0.00-100.0%
2016$4000.00-